Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: A longitudinal study

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 221-227

  Mishima, Shiho ^a   Omagari, Katsuhisa ^a   Ohba, Kazuo ^a   Kadokawa, Yoshiko ^a   Masuda, Jun Ichi ^a   Mishima, Ryosuke ^a   Kinoshita, Hideki ^a   Hayashida, Kenji ^a   Isomoto, Hajime ^a   Shikuwa, Saburo ^a   Mizuta, Yohei ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimitochondrial antibody; Autoimmune hepatitis; Liver histology; Longitudinal study; Western blotting

Indexed keywords

MITOCHONDRION ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT DISEASE; BILE DUCT INJURY; BIOCHEMISTRY; CHOLANGITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER HISTOLOGY; LONGITUDINAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BILE DUCTS, INTRAHEPATIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOBLOTTING; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER;

EID: 41549101402     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Talwalkar JA, Lindor KD: Primary biliary cirrhosis. Lancet 2003; 362:53-61.
2. Kaplan MM: Primary biliary cirrhosis. N Eng J Med 1996; 335:1570-1580.
3. Manns MP, Vogel A: Autoimmune hepatitis, from mechanisms to therapy. Hepatology 2006; 43:S132-144.
4. Yanagawa T, Miyakawa H, Shibata M, Kawaguchi N, Ishibashi M, Goto N, Mitamura K: Immunoreactivity to pyruvate dehydrogenase complex-E2 in well-defined patients with autoimmune hepatitis: Western blot analysis. Hepatol Res 2003; 26:81-86.
5. Zeniya M, Watanabe F, Morizane T, Shibata M, Maeyama S, Kage M, Nakanuma Y, Toda G, and Study Group of Intractable Liver Diseases for Research on a Specific Disease, Health Science Research Grant, Ministry of Health, Labour, and Welfare of Japan: Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model. J Gastroenterol 2005; 40:1148-1154.
6. Nezu S, Tanaka A, Yasui H, Imamura M, Nakajima H, Ishida H, Takahashi S: Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol 2006; 21:1448-1454.
7. Zen Y, Harada K, Sasaki M, Tsuneyama K, Matsui K, Haratake J, Sakisaka S, Maeyama S, Yamamoto K, Nakano M, Shimamatsu K, Kage M, Kurose N, Uchiyama A, Kaizaki Y, Toda G, Nakanuma Y: Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts. J Gastroenterol 2005; 40:164-170.
8. Sato Y, Harada K, Sudo Y, Watanabe K, Nakahama T, Morimoto H, Nakanuma Y: Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurative destructive cholangitis. Pathol Int 2002; 52:478-482.
9. Kadokawa Y, Omagari K, Ohba K, Masuda J, Hazama H, Kinoshita H, Ohnita K, Mizuta Y, Tanioka H, Imanishi T, Kohno S: Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the "phase" of the disease? Liver Int 2005; 25:317-324.
10. Alvarez F, Berg PA, Bianchi FB, et al: International Autoimmune Hepatitis Group Report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.
11. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, Yamada G, Hino K, Yokosuka O, Suzuki H: New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6:112-119.
12. Omagari K, Kadokawa Y, Ishihara Y, Kohno S: Clinical significance of antimitochondrial antibody by ELISA using "MESACUP-2 Test Mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Jpn J Med Pharm Sci 2003; 50:543-550. (In Japanese)
13. Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S: Evaluation of newly developed ELISA using "MESACUP-2 Test Mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003; 36:203-210.
14. Takemura M, Ohya K, Kojima K: Fundamental evaluation of "MESACUP-2 Test Mitochondrial M2". Jpn J Med Pharm Sci 2001; 46:809-816. (In Japanese)
15. Stanley CJ, Perham RN: Purification of 2-oxo-acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J 1980; 191:147-154.
16. Kinoshita H, Omagari K, Matsuo I, Yamaguchi K, Ikuno N, Kohno S: Frequency of IgG, IgM, and IgA class autoantibodies against 2-oxo-acid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis. Hepatol Res 1999; 15:163-171.
17. Farias AQ, Goncalves LL, Bittencourt PL, De Melo ES, Abrantes-Lemos CP, Porta G, Nakhle MC, Carrilho FJ, Cancado ELR: Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol 2006; 21:887-893.
18. Kenny RP, Czaja AJ, Ludwig J, Dickson ER: Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986; 31:705-711.
19. Chen Q-Y, Mackay IR, Fida S, Myers MA, Rowley MJ: Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognize different epitopes. J Autoimmun 1998; 11:151-161.
20. Masuda J, Omagari K, Miyakawa H, Hazama H, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Murata I, Kohno S: Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis. Autoimmunity 2002; 35:135-141.
21. Czaja AJ, Carpenter HA: Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001; 34:659-665.
22. Bach N, Thung SN, Schaffner F: The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992; 15:572-577.
23. Vergani D, Bogdanos D-P: Positive markers in AMA-negative PBC. Am J Gastroenterol 2003; 98:241-243.